Built from weaker models, sales multiples or analyst targets, so treat it as a rough guide.
Not used by alerts or posts.
Valued as a loss-making company: Sales comps and Analyst consensus.
ACCE opinionAir Products and Chemicals Inc. Common Stock (APD)
Fair value (3 models)
Not available
ACCE price target
$316
Rating
Not rated
Horizon
12 months
ACCE price target published on 18 Oct 2026, 00:00 CEST; previously $280 since 11 May 2026, 00:00 CEST.
Price used: $307 at the close on 23 Oct 2026, 22:00 CEST.
Models: Analyst consensus and Sales comps.
Fair value: the average of the applicable valuation models (discounted cash flow, multiples, residual income, dividend discount, shareholder yield), each run on the latest financial statements and the market price shown. Opinion columns (fair value, target, rating) are shown apart from the data. Full methodology: acceinvestments.com/data/how-we-value-stocks
Conflicts of interest: The author holds no personal position in this security. General statement
Produced by ACCE Investments (acceinvestments.com)
Data
ACCE score
50
out of 100
Analysts
70% buy
23 covering
1-year return
+20.5%
Dividend yield
2.35%
Air Products and Chemicals Inc. Common Stock in four questions
Plain answers, details below
Free accounts get 5 full stock pages a month, including the four answers.
Overview
ACCE thesis
Air Products makes industrial gases (oxygen, nitrogen, hydrogen, helium) and builds the on-site plants and pipelines that supply them to refiners, chemical makers, steelmakers and electronics fabs under long-term contracts, which is why its revenue is sticky. Its moat is that customers rarely switch gas suppliers once a plant sits on their site, and that structure underpins a 25.5% operating margin and 32.1% gross margin on 4.6% revenue growth. The near-term swing factor is hydrogen: the company's large green and blue hydrogen projects are the main source of its growth ambitions, and any slippage or capital overrun there would move the story more than the core gas business. The stock trades at a forward P/E of 19.9, a multiple that prices in steady execution rather than a re-rating, and the composite score of 44/100 reflects weak profitability signals on the trailing data (the reported trailing P/E and ROE are zero, so the trailing picture is incomplete). A deeper look should focus on project returns, capex discipline and whether the hydrogen backlog converts to cash on schedule.